Today Sabra Health Care REIT (SBRA) Hits New Lifetime High

Trade-Ideas LLC identified Sabra Health Care REIT (SBRA) as a new lifetime high candidate
By Jamie Hodge ,

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified

Sabra Health Care REIT

(

SBRA

) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Sabra Health Care REIT as such a stock due to the following factors:

  • SBRA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $16.4 million.
  • SBRA has traded 5,160 shares today.
  • SBRA is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in SBRA with the Ticky from Trade-Ideas. See the FREE profile for SBRA NOW at Trade-Ideas

More details on SBRA:

Sabra Health Care REIT, Inc. operates as a real estate investment trust in the United States. The company, through its subsidiaries, owns and invests in real estate properties for the healthcare industry. The stock currently has a dividend yield of 4.7%. SBRA has a PE ratio of 42.6. Currently there are 5 analysts that rate Sabra Health Care REIT a buy, 1 analyst rates it a sell, and 2 rate it a hold.

The average volume for Sabra Health Care REIT has been 497,600 shares per day over the past 30 days. Sabra Health Care REIT has a market cap of $2.0 billion and is part of the financial sector and real estate industry. The stock has a beta of 1.30 and a short float of 4.6% with 2.81 days to cover. Shares are up 12% year-to-date as of the close of trading on Friday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Sabra Health Care REIT as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, growth in earnings per share, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Highlights from the ratings report include:

  • The revenue growth greatly exceeded the industry average of 10.1%. Since the same quarter one year prior, revenues rose by 48.3%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
  • Looking at where the stock is today compared to one year ago, we find that it is not only higher, but it has also clearly outperformed the rise in the S&P 500 over the same period. Although other factors naturally played a role, the company's strong earnings growth was key. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.
  • SABRA HEALTH CARE REIT INC has improved earnings per share by 29.6% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, SABRA HEALTH CARE REIT INC increased its bottom line by earning $0.69 versus $0.67 in the prior year. This year, the market expects an improvement in earnings ($1.21 versus $0.69).
  • The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Real Estate Investment Trusts (REITs) industry average. The net income increased by 71.2% when compared to the same quarter one year prior, rising from $13.00 million to $22.25 million.
  • Net operating cash flow has slightly increased to $14.10 million or 9.38% when compared to the same quarter last year. Despite an increase in cash flow, SABRA HEALTH CARE REIT INC's average is still marginally south of the industry average growth rate of 11.97%.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null

Loading ...